4 completed, 2 terminated, 1 active not recruiting, 1 enrolling by invitation. 4 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Active not recruiting 1, Withdrawn 1 |
Follow Prokidney: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease Renal Autologous Cell Therapy (REACT), Sham Comparator - Type 2 Diabetes Mellitus, Chronic Kidney Diseases | Phase 3 | Withdrawn | Prokidney | 2024-07-17 | 2024-09-25 | |
| A Long-Term Follow-Up Study of Participants Exposed to REACT Renal Autologous Cell Therapy (REACT) - Diabetic Kidney Disease, Chronic Kidney Diseases | Recruiting | Prokidney | 80 | 2023-12-11 | 2026-09-01 | |
| Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product Renal Autologous Cell Therapy (REACT) - Diabetic Kidney Disease, Chronic Kidney Disease | Enrolling by invitation | Prokidney | 50 | 2023-11-23 | 2026-09-17 | |
| A Study of Participants With Chronic Kidney Disease Previously Treated With REACT Renal Autologous Cell Therapy (REACT) - Diabetic Kidney Disease, CAKUT | Phase 1 | Terminated | Prokidney | 1 | 2023-07-11 | 2025-02-28 |
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Renal Autologous Cell Therapy (REACT/ rilparencel), Sham Comparator - Type 2 Diabetes Mellitus, Chronic Kidney Diseases | Phase 3 | Active not recruiting | Prokidney | 685 | 2022-01-05 | 2026-08-11 |
| Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) Renal Autologous Cell Therapy (REACT) - Chronic Kidney Diseases, Type 1 Diabetes Mellitus | Phase 2 | Completed | Prokidney | 53 | 2021-07-27 | 2026-03-13 |
| A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). Renal Autologous Cell Therapy (REACT) - Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract | Phase 1 | Completed | Prokidney | 6 | 2019-08-13 | 2023-12-21 |
| A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease Renal Autologous Cell Therapy (REACT) - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Completed | Prokidney | 10 | 2018-04-25 | 2025-03-24 |
| A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Renal Autologous Cell Therapy (REACT), Renal Biopsy - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Completed | Prokidney | 83 | 2016-09-01 | 2025-08-24 |
| Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) Neo-Kidney Augment - Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Terminated | Prokidney | 1 | 2016-07-01 | 2021-04-23 |
Renal Insufficiency, Chronic (10) · Diabetes Mellitus, Type 2 (6) · Diabetic Nephropathies (3) · Cakut (2) · Diabetes Mellitus, Type 1 (1)
United States (9) · Mexico (1) · Puerto Rico (1) · Spain (1) · Taiwan (1)
Ashley Johns (1) · Ashley Johns, MSHS (1) · Brian Johnston (1) · Catherine Taylor (1)